|
1
|
Frazier Life Sciences Management
Palo Alto,
California
|
$613M
|
+$37.7M
|
+1,145,128
|
+7%
|
|
|
2
|
Capital World Investors
Los Angeles,
California
|
$414M
|
+$37M
|
+1,121,523
|
+10%
|
|
|
3
|
Fidelity Investments
Boston,
Massachusetts
|
$350M
|
+$51.9M
|
+1,573,852
|
+18%
|
|
|
4
|
RA Capital Management
Boston,
Massachusetts
|
$324M
|
–
|
–
|
–
|
|
|
5
|
FCPM III Services
Naarden,
Netherlands
|
$288M
|
-$23.3M
|
-708,547
|
-8%
|
|
|
6
|
Deerfield Management
New York
|
$145M
|
–
|
–
|
–
|
|
|
7
|
Viking Global Investors
Stamford,
Connecticut
|
$142M
|
–
|
–
|
–
|
|
|
8
|
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$129M
|
-$115M
|
-3,500,000
|
-48%
|
|
|
9
|
Maverick Capital
Dallas,
Texas
|
$111M
|
+$35.6M
|
+1,081,400
|
+49%
|
|
|
10
|
Duquesne Family Office
New York
|
$104M
|
–
|
–
|
–
|
|
|
11
|
|
$86M
|
+$83.6M
|
+2,535,682
|
New
|
|
|
12
|
Medicxi Ventures Management
St. Helier,
Jersey
|
$74.9M
|
-$15.3M
|
-465,543
|
-17%
|
|
|
13
|
Jennison Associates
New York
|
$71.2M
|
-$21.4M
|
-648,117
|
-24%
|
|
|
14
|
Orbis Allan Gray
Hamilton,
Bermuda
|
$59.2M
|
+$57.6M
|
+1,747,627
|
New
|
|
|
15
|
Polar Capital Holdings
London,
United Kingdom
|
$58.4M
|
-$36.5M
|
-1,107,089
|
-39%
|
|
|
16
|
Capital International Investors
Los Angeles,
California
|
$58.4M
|
+$9.3M
|
+282,364
|
+20%
|
|
|
17
|
|
$52.4M
|
-$13.2M
|
-401,463
|
-21%
|
|
|
18
|
Westfield Capital Management
Boston,
Massachusetts
|
$52.1M
|
-$22M
|
-666,441
|
-30%
|
|
|
19
|
Castle Hook Partners
New York
|
$46.5M
|
+$10.8M
|
+328,368
|
+31%
|
|
|
20
|
Ameriprise
Minneapolis,
Minnesota
|
$42.5M
|
+$16.5M
|
+500,495
|
+66%
|
|
|
21
|
AllianceBernstein
Nashville,
Tennessee
|
$40.3M
|
+$2M
|
+60,615
|
+5%
|
|
|
22
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$39.6M
|
+$38.5M
|
+1,167,357
|
New
|
|
|
23
|
|
$38.4M
|
+$8.2M
|
+248,727
|
+28%
|
|
|
24
|
Aberdeen Group
Edinburgh,
United Kingdom
|
$37.4M
|
+$8.76M
|
+265,780
|
+32%
|
|
|
25
|
|
$36.1M
|
+$5.84M
|
+177,134
|
+20%
|
|
